Author

Ana Fisic

BC Cancer Agency

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:variant calling· 2 Assay:whole-genome sequencing· 2 Research Focus:database / resource· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Janessa J. LaskiniD· 2 shared Karen Mungall· 2 shared Marco A. MarraiD· 2 shared Stephen S. F. YipiD· 2 shared Abbey Reisle· 1 shared Adam Kahnamelli· 1 shared Alexandra K. Fok· 1 shared Alexandra Roston· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Janessa J. LaskinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Parent-of-Origin-Aware Genomic Analysis to Enhance Cascade Testing in Pancreatic Cancer: A Population-Based Study

Pheobe TM Cheng, Carol Cremin, Lílian Córdova, Vahid Akbari, Tiffany Y. Leung, Eugene Cheung, Angela C. Bedard, Quan Hong, Ana Fisic, Jennifer Nuk, Mary‐Jill Asrat, Inglis Angela, Allison Mindlin, Melanie O’Loughlin, Katherine Dixon, , Kasmintan A Schrader

This study evaluates Parent-of-Origin-Aware genomic analysis (POAga) to improve cascade testing in pancreatic cancer families by clarifying familial risk.

medRxiv · Oct 31, 2026 · PreprintGenetic & Genomic Medicine

A Platform for Oncogenomic Reporting and Interpretation

Caralyn Reisle, Laura M. Williamson, Erin Pleasance, Anna Davies, Brayden Pellegrini, Dustin W. Bleile, Karen Mungall, Eric Chuah, Martin R. Jones, Yussanne P. Ma, Eleanor Lewis, Isaac Beckie, David Pham, Raphael Matiello Pletz, Amir Muhammadzadeh, , Steven J.M. Jones

PORI is an open-source platform for interpreting somatic variants in cancer, demonstrating that 88.2% of TCGA tumors have at least one potentially targetable alteration.

Nature Communications · Feb 9, 2022Peer-reviewedBioinformatics